Valuation
P/E Ratio -0,00x
P/B Ratio -0,00x
P/S Ratio —
P/FCF Ratio -0,00x
Margins
Gross Margin —
Operating Margin —
Net Margin —
PRIMTRACEUTICALS Share · CA74167D2041 · A2QB3W (XCNQ) Global X Management · Canada · Healthcare — real-time prices and quotes, company data, dividends, fundamentals, and AI-powered portfolio analysis on MoneyPeak
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of PRIMTRACEUTICALS
No Price
Asset Allocation
| Asset | Percentage % |
|---|---|
| Equity | 98,94 % |
Largest Positions
Updated on May 18 2026, 2:56 PM
| Symbol | ISIN | CUSIP | Name | Shares | Market Value | Percentage % |
|---|---|---|---|---|---|---|
| AKAM | US00971T1016 | 00971T101 | AKAMAI TECHNOLOGIES INC | 514.555 | 77,64 M EUR | 7,47 % |
| FTNT | US34959E1091 | 34959E109 | FORTINET INC | 628.508 | 77,17 M EUR | 7,43 % |
| PANW | US6974351057 | 697435105 | PALO ALTO NETWORKS INC | 295.507 | 71,76 M EUR | 6,91 % |
| CRWD | US22788C1053 | 22788C105 | CROWDSTRIKE HOLDINGS INC - A | 118.876 | 70,62 M EUR | 6,80 % |
| ZS | US98980G1022 | 98980G102 | ZSCALER INC | 405.485 | 65,3 M EUR | 6,29 % |
| OKTA | US6792951054 | 679295105 | OKTA INC | 719.484 | 59,55 M EUR | 5,73 % |
| GEN | US6687711084 | 668771108 | GEN DIGITAL INC | 2,06 M IDX | 48,06 M EUR | 4,63 % |
| RBRK | US7811541090 | 781154109 | RUBRIK INC-A | 747.313 | 47,66 M EUR | 4,59 % |
| S | US81730H1095 | 81730H109 | SENTINELONE INC -CLASS A | 2,81 M IDX | 47,32 M EUR | 4,55 % |
| SAIL | US78781J1097 | 78781J109 | SAILPOINT INC | 3,48 M IDX | 46,98 M EUR | 4,52 % |
Country Distribution
| Country | Percentage % |
|---|---|
| USA | 80,55 % |
| Israel | 6,40 % |
| Japan | 5,65 % |
| United Kingdom and Northern Ireland | 0,94 % |
| Other | 5,40 % |
Sector Distribution
| Sector | Percentage % |
|---|---|
| Technology | 93,54 % |
| Other | 5,40 % |
Industry Distribution
| Industry | Percentage % |
|---|---|
| Software - Infrastructure | 43,50 % |
| Software - Services | 42,93 % |
| Software - Application | 6,28 % |
| Information Technology Services | 0,83 % |
| Other | 5,40 % |
Currency Distribution
| Currency | Percentage % |
|---|---|
| USD | 85,04 % |
| EUR | 11,13 % |
| JPY | 1,83 % |
| GBP | 0,94 % |
Company Profile for PRIMTRACEUTICALS Share
Primo Nutraceuticals Inc. owns and develops commercial real estate properties for the cannabis cultivation sector in Canada. It offers built out turnkey facilities equipped with infrastructure to cannabis growers and processors. It owns hemp project in Oregon state and the greenhouse campus in Washington state. The company was formerly known as Bougainville Ventures Inc. and changed its name to Primo Nutraceuticals Inc. in October 2019. Primo Nutraceuticals Inc. was incorporated in 2014 and is based in Vancouver, Canada.
Fund Master Data
Issuer Global X Management
Asset Class ETF
Name Global X Funds - Global X Cybersecurity ETF
Fund Currency USD
Fund Key Figures
Fund Size 662.787,71 USD
Investment Strategy
The investment seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Indxx Cybersecurity Index. The fund invests at least 80% of its total assets in the securities of the underlying index and in American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs) based on the securities in the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from increased adoption of cybersecurity technology. The fund is non-diversified.
Updated on Aug 22 2021, 12:00 AM
Company Data
Name PRIMTRACEUTICALS
Company Primo Nutraceuticals Inc.
Primary Exchange 
CSE LISTED
CSE LISTED
WKN A2QB3W
ISIN CA74167D2041
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Richard Cindric
Country Canada
Currency EUR
Employees -
Address 890 West Pender Street, V6C 1J9 Vancouver
IPO Date 2019-04-22
Key Ratios
As of 03.07.2026
Stock Splits
| Date | Split |
|---|---|
| 26.08.2020 | 1:15 |
Ticker Symbols
| Name | Symbol |
|---|---|
| Over The Counter | BUGVF |
More Shares
Investors who hold PRIMTRACEUTICALS also have the following shares in their portfolio:
